203 related articles for article (PubMed ID: 31557610)
1. Transferrin conjugates of antitubercular drug isoniazid: Synthesis and in vitro efficacy.
Sutar YB; Mali JK; Telvekar VN; Rajmani RS; Singh A
Eur J Med Chem; 2019 Dec; 183():111713. PubMed ID: 31557610
[TBL] [Abstract][Full Text] [Related]
2. The Introduction of Hydrazone, Hydrazide, or Azepane Moieties to the Triterpenoid Core Enhances an Activity Against
Kazakova OB; Medvedeva NI; Smirnova IE; Lopatina TV; Veselovsky AV
Med Chem; 2021; 17(2):134-145. PubMed ID: 31939731
[TBL] [Abstract][Full Text] [Related]
3. Nanoparticle encapsulated lipopeptide conjugate of antitubercular drug isoniazid: in vitro intracellular activity and in vivo efficacy in a Guinea pig model of tuberculosis.
Horváti K; Bacsa B; Kiss E; Gyulai G; Fodor K; Balka G; Rusvai M; Szabó E; Hudecz F; Bősze S
Bioconjug Chem; 2014 Dec; 25(12):2260-8. PubMed ID: 25394206
[TBL] [Abstract][Full Text] [Related]
4. Peptide conjugates of therapeutically used antitubercular isoniazid-design, synthesis and antimycobacterial effect.
Horváti K; Mezo G; Szabó N; Hudecz F; Bosze S
J Pept Sci; 2009 May; 15(5):385-91. PubMed ID: 19319854
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and antimycobacterial property of PEG-bis(INH) conjugates.
Kakkar D; Tiwari AK; Chuttani K; Khanna A; Datta A; Singh H; Mishra AK
Chem Biol Drug Des; 2012 Aug; 80(2):245-53. PubMed ID: 22515497
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antimycobacterial activity of isoniazid derivatives from renewable fatty acids.
Rodrigues MO; Cantos JB; D'Oca CR; Soares KL; Coelho TS; Piovesan LA; Russowsky D; da Silva PA; D'Oca MG
Bioorg Med Chem; 2013 Nov; 21(22):6910-4. PubMed ID: 24103427
[TBL] [Abstract][Full Text] [Related]
7. New lipophilic isoniazid derivatives and their 1,3,4-oxadiazole analogues: Synthesis, antimycobacterial activity and investigation of their mechanism of action.
Vosátka R; Krátký M; Švarcová M; Janoušek J; Stolaříková J; Madacki J; Huszár S; Mikušová K; Korduláková J; Trejtnar F; Vinšová J
Eur J Med Chem; 2018 May; 151():824-835. PubMed ID: 29679902
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and antitubercular activity of substituted novel pyrazoline derivatives.
Ali MA; Yar MS; Kumar M; Pandian GS
Nat Prod Res; 2007 Jun; 21(7):575-9. PubMed ID: 17613813
[TBL] [Abstract][Full Text] [Related]
9. Hydrazone, benzohydrazones and isoniazid-acylhydrazones as potential antituberculosis agents.
Sampiron EG; Costacurta GF; Baldin VP; Almeida AL; Ieque AL; Santos NC; Alves-Olher VG; Vandresen F; Gimenes AC; Siqueira VL; Caleffi-Ferracioli KR; Cardoso RF; Scodro RB
Future Microbiol; 2019 Jul; 14():981-994. PubMed ID: 31382801
[No Abstract] [Full Text] [Related]
10. New INH-pyrazole analogs: Design, synthesis and evaluation of antitubercular and antibacterial activity.
Nayak N; Ramprasad J; Dalimba U
Bioorg Med Chem Lett; 2015 Dec; 25(23):5540-5. PubMed ID: 26520663
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and biological evaluation of novel isoniazid derivatives with potent antitubercular activity.
Martins F; Santos S; Ventura C; Elvas-Leitão R; Santos L; Vitorino S; Reis M; Miranda V; Correia HF; Aires-de-Sousa J; Kovalishyn V; Latino DA; Ramos J; Viveiros M
Eur J Med Chem; 2014 Jun; 81():119-38. PubMed ID: 24836065
[TBL] [Abstract][Full Text] [Related]
12. Development of a three component complex to increase isoniazid efficacy against isoniazid resistant and nonresistant Mycobacterium tuberculosis.
Manning T; Plummer S; Baker T; Wylie G; Clingenpeel AC; Phillips D
Bioorg Med Chem Lett; 2015 Oct; 25(20):4621-7. PubMed ID: 26341133
[TBL] [Abstract][Full Text] [Related]
13. The Effects Study of Isoniazid Conjugated Multi-Wall Carbon Nanotubes Nanofluid on
Zomorodbakhsh S; Abbasian Y; Naghinejad M; Sheikhpour M
Int J Nanomedicine; 2020; 15():5901-5909. PubMed ID: 32884258
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of novel 1,2,3-triazole derivatives of isoniazid and their in vitro and in vivo antimycobacterial activity evaluation.
Kumar D; Beena ; Khare G; Kidwai S; Tyagi AK; Singh R; Rawat DS
Eur J Med Chem; 2014 Jun; 81():301-13. PubMed ID: 24852277
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and In Vitro Antimycobacterial and Antibacterial Activity of 8-OMe Ciprofloxacin-Hydrozone/Azole Hybrids.
Xu Z; Zhang S; Feng LS; Li XN; Huang GC; Chai Y; Lv ZS; Guo HY; Liu ML
Molecules; 2017 Jul; 22(7):. PubMed ID: 28703766
[TBL] [Abstract][Full Text] [Related]
16. Structure elaboration of isoniazid: synthesis, in silico molecular docking and antimycobacterial activity of isoniazid-pyrimidine conjugates.
Kaur H; Singh L; Chibale K; Singh K
Mol Divers; 2020 Nov; 24(4):949-955. PubMed ID: 31691051
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo activities of acylated derivatives of isoniazid against mycobacterium tuberculosis.
Hearn MJ; Cynamon MH
Drug Des Discov; 2003; 18(4):103-8. PubMed ID: 15553921
[TBL] [Abstract][Full Text] [Related]
18. Anti-Mycobacterium tuberculosis activity of naphthoimidazoles combined with isoniazid and rifampicin.
Corrêa Barros LP; Del Rio KP; Carvalho TDSC; Pinto MDCFR; de Moura KCG; Halicki PCB; Ramos DF; da Silva PEA
Tuberculosis (Edinb); 2018 Jul; 111():198-201. PubMed ID: 30029908
[TBL] [Abstract][Full Text] [Related]
19. Reversed isoniazids: Design, synthesis and evaluation against Mycobacterium tuberculosis.
Kumar M; Singh K; Ngwane AH; Hamzabegovic F; Abate G; Baker B; Wiid I; Hoft DF; Ruminski P; Chibale K
Bioorg Med Chem; 2018 Feb; 26(4):833-844. PubMed ID: 29373270
[TBL] [Abstract][Full Text] [Related]
20. Microwave assisted one-pot synthesis of highly potent novel isoniazid analogues.
Manjashetty TH; Yogeeswari P; Sriram D
Bioorg Med Chem Lett; 2011 Apr; 21(7):2125-8. PubMed ID: 21320779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
